Korea needs speedy mergers of several research centers among major drug makers

Published: 2008-05-14 07:00:00

Updated: 2008-05-14 07:00:00

Large domestic pharmaceutical companies should focus on research and development (R&D) of new drugs in a form to create a new research center merging several research laboratories, according to pharmaceutical observers.

Observers say Korea can no longer depend on sales of generic drugs, adding...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK